'Magic mushrooms' ingredient beneficial to cancer patients, report says

Researchers find psilocybin improved the anxiety and depression of terminal cancer patients for up to six months. The study is considered a first step in restoring the hallucinogen's respectability. The psychedelic drug psilocybin, the active ingredient in "magic mushrooms," can improve mood and reduce anxiety and depression in terminal cancer patients, Los Angeles researchers reported Monday.

Should We Give Cancer Patients 'Magic Mushrooms'?

According to a new study, psilocybin, the active ingredient in "magic mushrooms" has a beneficial psychological impact on terminal cancer patients. Researchers in Los Angeles found that the hallucinogen reduced anxiety and depression, giving patients peace in their final days. The experiment involved 12 subjects with advanced-stage cancer between the ages of 36 and 58. While some are skeptical ...

Mother given weeks to live after cancer was missed by ELEVEN doctors

Angela Skeffington claims ten hospital doctors and her own GP misdiagnosed the disease as period pains, depression and indigestion.

Motorcycle Cancer Risk Campaign for EMF Magnetic Field Radiation Rider Safety

Safety-Environment-Future is the focus of the International Motorcycle Safety Conference . Randall Dale Chipkar hopes for resolutions reducing rider health risk regarding cancer-controversial ELF EMF radiation emission penetrating up through motorcycle seats.

Cancer and Magic Mushrooms: Study Shows Magic Mushroom Ingredient Improves Anxiety in Terminal Cancer Patients

Cancer and magic mushrooms – you’d never think the two can go together in a sentence, but UCLA researchers suggest that cancer patients can benefit from psilocybin, the active ingredient found in magic mushrooms. In an initial study to see if 12 adults, ages 36 to 58, who had advanced-stage cancer could have positive health effects with the use of hallucinogens as a form of treatment ...